Effect of once ‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - July 17, 2018 Category: Endocrinology Authors: Stefan Korsatko MD , Lene Jensen PhD , Martina Brunner MSc , Stefanie Sach ‐Friedl MSc , Maja D. Tarp MSc , Anders G. Holst MD , Simon R. Heller MD , Thomas R. Pieber MD Source Type: research